서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 9 of 9

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2008	Anti-cancer effect of the combined therapy of anti-EGFR antibody and tyrosine kinase inhibitor in oral squamous cell carcinoma 박성진	link
2009-01	Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer Han, S-W; Oh, D-Y; Im, S-A; Park, S. R.; Lee, K-W; Song, H. S.; Lee, N-S; Lee, K. H.; Choi, I. S.; Lee, M. H.; Kim, M. A.; Kim, W. H.; Bang, Y-J; Kim, T-Y British Journal of Cancer, Vol.100 No.2, pp.298-304	DOI
2011-04	Cetuximab plus irinotecan in pretreated metastatic colorectal cancer patients: The ELSIE study Lim, Robert; Sun, Yan; Im, Seock-Ah; Hsieh, Ruey-Kuen; Yau, Tsz Kok; Bonaventura, Anthony; Cheirsilpa, Arkom; Esser, Regina; Mueser, Matthias; Advani, Suresh World Journal of Gastroenterology, Vol.17 No.14, pp.1879-1888	DOI
2011-10	Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer Park, Jin Hyun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Jeong, Seung-Yong; Park, Kyu Joo; Kim, Tae-You; Bang, Yung-Jue; Park, Jae-Gahb Cancer Chemotherapy and Pharmacology, Vol.68 No.4, pp.1045-1055	DOI
2011-11	Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: A multicenter phase II study Kim, Sun Young; Hong, Yong Sang; Kim, Dae Yong; Kim, Tae Won; Kim, Jee Hyun; Im, Seok Ah; Lee, Keun Seok; Yun, Tak; Jeong, Seung-Yong; Choi, Hyo Seong; Lim, Seok-Byung; Chang, Hee Jin; Jung, Kyung Hae International Journal of Radiation Oncology Biology Physics, Vol.81 No.3, pp.677-683	DOI
2012-03	Adverse pulmonary reactions associated with the use of monoclonal antibodies in cancer patients Kang, Hyo Jae; Park, Jong Sun; Kim, Dong-Wan; Lee, Jinwoo; Jeong, Yun Jeong; Choi, Sun Mi; Lee, Sang-Min; Yang, Seok-Chul; Yoo, Chul-Gyu; Kim, Young Whan; Han, Sung Koo; Yim, Jae-Joon Respiratory Medicine, Vol.106 No.3, pp.443-450	DOI
2016-07	Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma Michel, Loren; Ley, Jessica; Wildes, Tanya M.; Schaffer, Andras; Robinson, Anthony; Chun, Se-Eun; Lee, Wooin; Lewis, James, Jr.; Trinkaus, Kathryn; Adkins, Douglas Oral Oncology, Vol.58, pp.41-48	DOI
2019-09	GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer Park, Ji Eun; Jin, Mei Hua; Hur, Minkyu; Nam, Ah-Rong; Bang, Ju-Hee; Won, Jonghwa; Oh, Do-Youn; Bang, Yung-Jue Gastric Cancer, Vol.22 No.5, pp.932-940	DOI
2023-11	Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study Oh, Do-Youn; Maqueda, Maria Alsina; Quinn, David I.; O’Dwyer, Peter J.; Chau, Ian; Kim, Sun Young; Duran, Ignacio; Castellano, Daniel; Berlin, Jordan; Mellado, Begona; Williamson, Stephen K.; Lee, Keun-Wook; Marti, Francisca; Mathew, Paul; Saif, Muhammad W.; Wang, Ding; Chong, Elizabeth; Hilger-Rolfe, Jacqueline; Dean, James P.; Arkenau, Hendrik-Tobias BMC Cancer, Vol.23(1):1056	view file DOI

1